Cornell University - Visit www.cornell.edu Kirby Research Group at Cornell: Microfluidics and Nanofluidics : - Home College of Engineering - visit www.engr.cornell.edu Cornell University - Visit www.cornell.edu
Cornell University, College of Engineering Search Cornell
News Contact Info Login
Micro/Nanofluidics Laboratory: Research Interests

Our general research interests include:

Click here for specific research projects.

Cornell Micro/Nanofluidics Laboratory News

Scientific American reports on blood tests for cancer
Demystifying circulating tumor cells
Medical Device Daily reports on GEDI device
The Force is with us: GEDI chip sorts prostate cancer cells
Rouillard reports on mechanical regulation of fibroblasts
Presentan en NY avances para personalizar tratamientos contra cáncer
Cornell demonstrates functional characterization of circulating tumor cells
Lannin wins NSF fellowship
Pratt wins CMM Young Investigator Award
Polacheck reports on cancer cell migration in PNAS
Barbati to chair international Gordon Research Seminar on Microfluidics
Announcing the 2011 Microfluidics GRC
Kirbylab receives grant for genetic analysis of circulating tumor cells
Multi-institutional team chosen to probe cytoskeletal architecture in CTCs
Hawkins reports on automated characterization of Mycobacterium
Pratt and Huang report on rare cell capture in microfluidic devices
Link between substrate stiffness and adipose differentiation reported
Rouillard reports on high-viability photocrosslinked alginate
Kirby to present at CTC Meeting in San Francisco
Kirby to present at Lorentz CTC workshop
Hawkins reports on electrothermal flow in dielectrophoresis devices
Nelson reports MALDI-MS on EWOD devices
Chlorella vulgaris cultured in replete (left) and nitrogen-limited (right) growth media.
A microchip used to capture circulating tumor cells from the peripheral blood of castrate-resistant prostate cancer patients.
A circulating tumor cell captured from the peripheral blood of a castrate-resistant prostate cancer patient, using geometrically enhanced differential immunocapture.